KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
Tumours use various strategies to evade immune surveillance,. Immunotherapies targeting
tumour immune evasion such as immune checkpoint blockade have shown considerable …
tumour immune evasion such as immune checkpoint blockade have shown considerable …
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
SM Zhang, WL Cai, X Liu, D Thakral, J Luo… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Tumours use various strategies to evade immune surveillance 1, 2. Immunotherapies
targeting tumour immune evasion such as immune checkpoint blockade have shown …
targeting tumour immune evasion such as immune checkpoint blockade have shown …
[HTML][HTML] KDM5B Promotes Immune Evasion by Recruiting SETDB1 to Silence Retroelements
SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan… - Nature, 2021 - ncbi.nlm.nih.gov
Tumors utilize various strategies to evade immune surveillance 1, 2. Immunotherapies
targeting tumor immune evasion such as immune checkpoint blockade have shown …
targeting tumor immune evasion such as immune checkpoint blockade have shown …
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
SM Zhang, WL Cai, X Liu, D Thakral, J Luo… - …, 2021 - ui.adsabs.harvard.edu
Tumours use various strategies to evade immune surveillance 1, 2. Immunotherapies
targeting tumour immune evasion such as immune checkpoint blockade have shown …
targeting tumour immune evasion such as immune checkpoint blockade have shown …
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan… - Nature, 2021 - ideas.repec.org
Tumours use various strategies to evade immune surveillance1, 2. Immunotherapies
targeting tumour immune evasion such as immune checkpoint blockade have shown …
targeting tumour immune evasion such as immune checkpoint blockade have shown …
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan… - Nature, 2021 - econpapers.repec.org
Tumours use various strategies to evade immune surveillance1, 2. Immunotherapies
targeting tumour immune evasion such as immune checkpoint blockade have shown …
targeting tumour immune evasion such as immune checkpoint blockade have shown …
[引用][C] KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan… - Nature, 2021 - cir.nii.ac.jp
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan… - paper.sciencenet.cn
Tumours use various strategies to evade immune surveillance1, 2. Immunotherapies
targeting tumour immune evasion such as immune checkpoint blockade have shown …
targeting tumour immune evasion such as immune checkpoint blockade have shown …
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.
SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan… - Nature, 2021 - europepmc.org
Tumors utilize various strategies to evade immune surveillance 1, 2. Immunotherapies
targeting tumor immune evasion such as immune checkpoint blockade have shown …
targeting tumor immune evasion such as immune checkpoint blockade have shown …